| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Program in Neuroscience and Department of Physiology, University of Maryland at Baltimore, School of Medicine, Baltimore, Maryland 21201
Address all correspondence and requests for reprints to: Stuart K. Amateau, Department of Physiology, University of Maryland at Baltimore, School of Medicine, 655 West Baltimore Street, Bressler RB 5020, Baltimore, Maryland 21201. E-mail: samat001{at}umaryland.edu
Accurate assessment of gonadal steroid levels in the developing brain is critical for understanding naturally occurring steroid-mediated sexual differentiation as well as determining the physiological relevance of exogenous steroid treatments commonly used in the study of this phenomenon. Using RIA, we measured the estradiol (E2) content of six regions of the developing brain immediately post partum, 1 d post partum, and after injection of exogenous estradiol benzoate, testosterone propionate, or the aromatase inhibitor formestane. We found sexually dimorphic E2 content in several regions of the newborn brain. At 2 h of life, there was significantly higher E2 content in males vs. females in the frontal cortex, hypothalamus and preoptic area but not in the hippocampus, brainstem, or cerebellum. Surprisingly, the female hippocampus had significantly higher E2 content than all other female regions examined. By d 1 post partum, E2 levels had decreased precipitously in most brain regions, and only the hypothalamus maintained a sex difference. Injection of female pups with estradiol benzoate raised tissue levels to that of the male in the hypothalamus but 2- to 3-fold higher in the other five regions. Testosterone administration increased E2 content exclusively in the preoptic area, suggesting local variation in aromatase activity and/or substrate availability. Central administration of formestane decreased estrogen content in the male cortex, hypothalamus, and preoptic area. Formestane treatment also decreased endogenous E2 in female cortex and hippocampus, suggesting de novo synthesis selectively in these brain regions. These data corroborate and extend previous findings of sex differences in brain E2 levels perinatally and reveal an unexpected regional heterogeneity in E2 synthesis and/or metabolism.
This article has been cited by other articles:
![]() |
M. M. McCARTHY Estradiol and the Developing Brain Physiol Rev, January 1, 2008; 88(1): 91 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Speert, A. T. M. Konkle, S. L. Zup, J. M. Schwarz, C. Shiroor, M. E. Taylor, and M. M. McCarthy Focal Adhesion Kinase and Paxillin: Novel Regulators of Brain Sexual Differentiation? Endocrinology, July 1, 2007; 148(7): 3391 - 3401. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Jelks, R. Wylie, C. L. Floyd, A. K. McAllister, and P. Wise Estradiol Targets Synaptic Proteins to Induce Glutamatergic Synapse Formation in Cultured Hippocampal Neurons: Critical Role of Estrogen Receptor-{alpha} J. Neurosci., June 27, 2007; 27(26): 6903 - 6913. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Hilton, L. L. Bambrick, S. M. Thompson, and M. M. McCarthy Estradiol Modulation of Kainic Acid-Induced Calcium Elevation in Neonatal Hippocampal Neurons Endocrinology, March 1, 2006; 147(3): 1246 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bodo, A. E. Kudwa, and E. F. Rissman Both Estrogen Receptor-{alpha} and -{beta} Are Required for Sexual Differentiation of the Anteroventral Periventricular Area in Mice Endocrinology, January 1, 2006; 147(1): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Baum Possible Contribution of Neonatal Ligand-Independent Activation of Estradiol Receptors to Male-Typical Sexual Differentiation of Brain and Behavior Endocrinology, September 1, 2005; 146(9): 3702 - 3704. [Full Text] [PDF] |
||||
![]() |
K. M. Olesen, H. M. Jessen, C. J. Auger, and A. P. Auger Dopaminergic Activation of Estrogen Receptors in Neonatal Brain Alters Progestin Receptor Expression and Juvenile Social Play Behavior Endocrinology, September 1, 2005; 146(9): 3705 - 3712. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Toran-Allerand, A. A. Tinnikov, R. J. Singh, and I. S. Nethrapalli 17{alpha}-Estradiol: A Brain-Active Estrogen? Endocrinology, September 1, 2005; 146(9): 3843 - 3850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Cornil, C. Dalla, Z. Papadopoulou-Daifoti, M. Baillien, C. Dejace, G. F. Ball, and J. Balthazart Rapid Decreases in Preoptic Aromatase Activity and Brain Monoamine Concentrations after Engaging in Male Sexual Behavior Endocrinology, September 1, 2005; 146(9): 3809 - 3820. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Miller, T. Jover, H. W. Cohen, R. S. Zukin, and A. M. Etgen Estrogen Can Act via Estrogen Receptor {alpha} and {beta} to Protect Hippocampal Neurons against Global Ischemia-Induced Cell Death Endocrinology, July 1, 2005; 146(7): 3070 - 3079. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |